Dynavax (DVAX) Gains as Medigen Rolls Out COVID-19 Vaccine

Published on August 24, 2021

Dynavax (DVAX) stock gains as partner Medigen announces launch of its COVID-19 vaccine MVC-COV1901 adjuvanted with CpG 1018 of the former.

Continue reading on website
Other news

The 5 secrets to having an unbreakable will

August 24, 2021
What exactly is an unbreakable will? It's when you fully commit to your goals and refuse to let anything get in your way.

Here's Why Prudent Investors are Buying SM Energy (SM) Now

August 24, 2021
SM Energy's (SM) increasing focus on crude, specifically in the Permian Basin and Eagle Ford areas, to enable it to boost oil-weighted activity in the...